blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3399044

EP3399044 - METHOD FOR PRODUCING HEPARAN SULFATE HAVING ANTICOAGULANT ACTIVITY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.12.2021
Database last updated on 14.09.2024
FormerThe patent has been granted
Status updated on  01.01.2021
FormerGrant of patent is intended
Status updated on  26.07.2020
FormerRequest for examination was made
Status updated on  05.10.2018
FormerThe international publication has been made
Status updated on  07.07.2017
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024 [2024/42]
Applicant(s)For all designated states
Ajinomoto Co., Inc.
15-1, Kyobashi 1-chome Chuo-ku
Tokyo 104-8315 / JP
[2018/45]
Inventor(s)01 / TOKURA, Yuriko
c/o Ajinomoto Co. Inc.
1-1 Suzuki-cho
Kawasaki-ku
Kawasaki-shi Kanagawa 210-8681 / JP
 [2018/45]
Representative(s)Strehl Schübel-Hopf & Partner
Maximilianstrasse 54
80538 München / DE
[2018/45]
Application number, filing date16881650.216.12.2016
[2018/45]
WO2016JP87688
Priority number, dateJP2015025698828.12.2015         Original published format: JP 2015256988
[2018/45]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017115674
Date:06.07.2017
Language:JA
[2017/27]
Type: A1 Application with search report 
No.:EP3399044
Date:07.11.2018
Language:EN
[2018/45]
Type: B1 Patent specification 
No.:EP3399044
Date:03.02.2021
Language:EN
[2021/05]
Search report(s)International search report - published on:JP06.07.2017
(Supplementary) European search report - dispatched on:EP04.07.2019
ClassificationIPC:C12P19/04, C08B37/10, A61K31/727, A61P7/02, C12N9/14, C12N15/09, C12P19/26
[2019/32]
CPC:
C12P19/04 (EP,US); A61P7/02 (EP,US); C12P19/26 (EP,US);
A61K31/727 (EP,US); C12N15/09 (EP,US); C12N9/14 (EP,US);
C12Y402/02008 (EP,US) (-)
Former IPC [2018/45]C12P19/04, C08B37/10, A61K31/727, A61P7/02, C12N9/14, C12N15/09
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/45]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON HEPARANSULFAT MIT ANTIKOAGULIERENDER WIRKUNG[2018/45]
English:METHOD FOR PRODUCING HEPARAN SULFATE HAVING ANTICOAGULANT ACTIVITY[2018/45]
French:PROCÉDÉ DE PRODUCTION DE SULFATE D'HÉPARANE À ACTIVITÉ ANTICOAGULANTE[2018/45]
Entry into regional phase19.06.2018Translation filed 
28.07.2018National basic fee paid 
28.07.2018Search fee paid 
28.07.2018Designation fee(s) paid 
28.07.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
28.07.2018Examination requested  [2018/45]
28.01.2020Amendment by applicant (claims and/or description)
27.07.2020Communication of intention to grant the patent
23.10.2020Receipt of the translation of the claim(s)
30.11.2020Fee for grant paid
30.11.2020Fee for publishing/printing paid
Opposition(s)04.11.2021No opposition filed within time limit [2022/02]
Fees paidRenewal fee
19.12.2018Renewal fee patent year 03
23.12.2019Renewal fee patent year 04
24.12.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL03.02.2021
AT03.02.2021
CY03.02.2021
DK03.02.2021
EE03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
MC03.02.2021
MK03.02.2021
MT03.02.2021
PL03.02.2021
RO03.02.2021
RS03.02.2021
SE03.02.2021
SI03.02.2021
SK03.02.2021
SM03.02.2021
TR03.02.2021
NO03.05.2021
GR04.05.2021
IS03.06.2021
PT04.06.2021
[2024/42]
Former [2024/29]AL03.02.2021
AT03.02.2021
CY03.02.2021
DK03.02.2021
EE03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
MC03.02.2021
MK03.02.2021
PL03.02.2021
RO03.02.2021
RS03.02.2021
SE03.02.2021
SI03.02.2021
SK03.02.2021
SM03.02.2021
TR03.02.2021
NO03.05.2021
GR04.05.2021
IS03.06.2021
PT04.06.2021
Former [2024/22]AL03.02.2021
AT03.02.2021
CY03.02.2021
DK03.02.2021
EE03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
MC03.02.2021
MK03.02.2021
PL03.02.2021
RO03.02.2021
RS03.02.2021
SE03.02.2021
SI03.02.2021
SK03.02.2021
SM03.02.2021
NO03.05.2021
GR04.05.2021
IS03.06.2021
PT04.06.2021
Former [2023/30]AL03.02.2021
AT03.02.2021
CY03.02.2021
DK03.02.2021
EE03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
MC03.02.2021
PL03.02.2021
RO03.02.2021
RS03.02.2021
SE03.02.2021
SI03.02.2021
SK03.02.2021
SM03.02.2021
NO03.05.2021
GR04.05.2021
IS03.06.2021
PT04.06.2021
Former [2022/33]AL03.02.2021
AT03.02.2021
DK03.02.2021
EE03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
MC03.02.2021
PL03.02.2021
RO03.02.2021
RS03.02.2021
SE03.02.2021
SI03.02.2021
SK03.02.2021
SM03.02.2021
NO03.05.2021
GR04.05.2021
IS03.06.2021
PT04.06.2021
Former [2022/23]AL03.02.2021
AT03.02.2021
DK03.02.2021
EE03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
PL03.02.2021
RO03.02.2021
RS03.02.2021
SE03.02.2021
SI03.02.2021
SK03.02.2021
SM03.02.2021
NO03.05.2021
GR04.05.2021
IS03.06.2021
PT04.06.2021
Former [2022/13]AL03.02.2021
AT03.02.2021
DK03.02.2021
EE03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
PL03.02.2021
RO03.02.2021
RS03.02.2021
SE03.02.2021
SI03.02.2021
SK03.02.2021
SM03.02.2021
NO03.05.2021
GR04.05.2021
PT04.06.2021
Former [2022/10]AL03.02.2021
AT03.02.2021
DK03.02.2021
EE03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
PL03.02.2021
RO03.02.2021
RS03.02.2021
SE03.02.2021
SK03.02.2021
SM03.02.2021
NO03.05.2021
GR04.05.2021
PT04.06.2021
Former [2022/07]AL03.02.2021
AT03.02.2021
DK03.02.2021
EE03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
PL03.02.2021
RO03.02.2021
RS03.02.2021
SE03.02.2021
SK03.02.2021
SM03.02.2021
NO03.05.2021
GR04.05.2021
IS03.06.2021
PT04.06.2021
Former [2021/50]AT03.02.2021
DK03.02.2021
EE03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
PL03.02.2021
RO03.02.2021
RS03.02.2021
SE03.02.2021
SK03.02.2021
SM03.02.2021
NO03.05.2021
GR04.05.2021
IS03.06.2021
PT04.06.2021
Former [2021/49]AT03.02.2021
DK03.02.2021
EE03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
PL03.02.2021
RS03.02.2021
SE03.02.2021
SM03.02.2021
NO03.05.2021
GR04.05.2021
IS03.06.2021
PT04.06.2021
Former [2021/48]AT03.02.2021
EE03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
PL03.02.2021
RS03.02.2021
SE03.02.2021
SM03.02.2021
NO03.05.2021
GR04.05.2021
IS03.06.2021
PT04.06.2021
Former [2021/46]AT03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
PL03.02.2021
RS03.02.2021
SE03.02.2021
SM03.02.2021
NO03.05.2021
GR04.05.2021
IS03.06.2021
PT04.06.2021
Former [2021/42]AT03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
PL03.02.2021
RS03.02.2021
SE03.02.2021
NO03.05.2021
GR04.05.2021
IS03.06.2021
PT04.06.2021
Former [2021/39]AT03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
PL03.02.2021
RS03.02.2021
SE03.02.2021
NO03.05.2021
GR04.05.2021
PT04.06.2021
Former [2021/38]AT03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
RS03.02.2021
SE03.02.2021
NO03.05.2021
GR04.05.2021
PT04.06.2021
Former [2021/37]AT03.02.2021
FI03.02.2021
HR03.02.2021
LT03.02.2021
LV03.02.2021
RS03.02.2021
NO03.05.2021
GR04.05.2021
PT04.06.2021
Former [2021/36]FI03.02.2021
HR03.02.2021
LT03.02.2021
NO03.05.2021
GR04.05.2021
PT04.06.2021
Former [2021/35]FI03.02.2021
HR03.02.2021
LT03.02.2021
NO03.05.2021
PT04.06.2021
Former [2021/33]FI03.02.2021
LT03.02.2021
NO03.05.2021
PT04.06.2021
Documents cited:Search[Y]US2008032349  (VISKOV CHRISTIAN [FR], et al) [Y] 1-13 * paragraphs [0005] - [0007] *;
 [Y]WO2012116048  (RENSSELAER POLYTECH INST [US], et al) [Y] 1-13 * page 2, lines 14-20; figure -; claim - *;
 [YP]EP3054005  (AJINOMOTO KK [JP]) [YP] 1-13 * paragraph [0261]; claim - *;
 [Y]  - WU JINGJUN ET AL, "Controllable production of low molecular weight heparins by combinations of heparinase I/II/III", CARBOHYDRATE POLYMERS, APPLIED SCIENCE PUBLISHERS, LTD. BARKING, GB, (20130923), vol. 101, doi:10.1016/J.CARBPOL.2013.09.052, ISSN 0144-8617, pages 484 - 492, XP028790571 [Y] 1-13 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.carbpol.2013.09.052
International search[Y]WO2004050673  (MASSACHUSETTS INST TECHNOLOGY [US], et al) [Y] 1-13 * , claims; example 19 & US 2008/0207895 A1 claims; example 19 *;
 [A]JP2007501305  (Inalco S.p.A.) [A] 1-13 * , claims & US 2007/0042993 A1 & WO 2005/014656 A1 & EP 1654288 A & KR 10-2006-0063933 A & CN 1832966 A *;
 [A]JP2007517771  (Momenta Pharmaceuticals, Inc.) [A] 1-13* , & US 2005/0207988 A1 & WO 2005/032483 A2 & EP 1667633 A *;
 [Y]JP2008512105  (Aventis Pharma S.A.) [Y] 1-13 * , paragraphs [0005] to [0007] & US 2008/0032349 A1 paragraphs [0005], [0006] & WO 2006/030099 A1 & EP 1791947 A *;
 [Y]WO2015050184  (AJINOMOTO KK [JP]) [Y] 1-13 * , paragraphs [0260] to [0272] & US 2016/0201103 A1 paragraphs [0386] to [0398] & EP 3054005 A1 *;
 [Y]  - CHAI, WENGANG et al., "Relative Susceptibilities of the Glucosamine-Glucuronic Acid and N-Acetylglucosamine-Glucuronic Acid Linkages to Heparin Lyase III", Biochemistry, (20040000), vol. 43, no. 26, pages 8590 - 8599, XP055396250 [Y] 1-13 * ABSTRACT, MATERIALS AND METHODS *

DOI:   http://dx.doi.org/10.1021/bi036250k
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.